148 related articles for article (PubMed ID: 6149285)
1. Psychopharmacological investigation of the monoamine oxidase inhibitory activity of molindone, a dihydroindolone neuroleptic.
Balsara JJ; Gada VP; Nandal NV; Chandorkar AG
J Pharm Pharmacol; 1984 Sep; 36(9):608-13. PubMed ID: 6149285
[TBL] [Abstract][Full Text] [Related]
2. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
Conway P; Uretsky NJ
Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
[TBL] [Abstract][Full Text] [Related]
3. Small doses of apomorphine induce catalepsy and antagonize methamphetamine stereotypy in rats.
Balsara JJ; Bapat TR; Gada VP; Chandorkar AG
Psychopharmacology (Berl); 1982; 78(2):192-4. PubMed ID: 6817377
[TBL] [Abstract][Full Text] [Related]
4. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. I. Psychopharmacological profile in rodents.
Worms P; Kan JP; Wermuth CG; Roncucci R; Bizière K
J Pharmacol Exp Ther; 1987 Jan; 240(1):241-50. PubMed ID: 3100770
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of apomorphine-induced cage climbing behaviour and methamphetamine stereotypy by fenfluramine in mice.
Gada VP; Joshi VV; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1984; 28(4):326-30. PubMed ID: 6543532
[TBL] [Abstract][Full Text] [Related]
6. Relationship between extracellular 5-hydroxytryptamine and behaviour following monoamine oxidase inhibition and L-tryptophan.
Sleight AJ; Marsden CA; Martin KF; Palfreyman MG
Br J Pharmacol; 1988 Feb; 93(2):303-10. PubMed ID: 2451963
[TBL] [Abstract][Full Text] [Related]
7. Experimental evaluation of the antidepressant and neuroleptic activity of maprotiline.
Balsara JJ; Nandal NV; Mane VR; Chandorkar AG
Indian J Physiol Pharmacol; 1982; 26(3):183-95. PubMed ID: 6129195
[TBL] [Abstract][Full Text] [Related]
8. The effects of putative 5-hydroxytryptamine antagonists on the behaviour produced by administration of tranylcypromine and L-tryptophan or tranylcypromine and L-DOPA to rats.
Deakin JF; Green AR
Br J Pharmacol; 1978 Oct; 64(2):201-9. PubMed ID: 708990
[TBL] [Abstract][Full Text] [Related]
9. Effects of amantadine on modification of dopamine dependent behaviours by molindone.
Dhaware BS; Balsara JJ; Nandal NV; Chandorkar AG
Indian J Med Sci; 2000 Aug; 54(8):321-4. PubMed ID: 11143744
[TBL] [Abstract][Full Text] [Related]
10. Effects of dextromethorphan on dopamine dependent behaviours in rats.
Gaikwad RV; Gaonkar RK; Jadhav SA; Thorat VM; Jadhav JH; Balsara JJ
Indian J Exp Biol; 2007 Aug; 45(8):712-9. PubMed ID: 17877148
[TBL] [Abstract][Full Text] [Related]
11. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a ginkgo biloba extract (EGb 761) in functional tests for monoamine oxidase inhibition.
Porsolt RD; Roux S; Drieu K
Arzneimittelforschung; 2000 Mar; 50(3):232-5. PubMed ID: 10758773
[TBL] [Abstract][Full Text] [Related]
13. Psychopharmacological profile of mesterolone.
Baran L; Przegaliński E
Pol J Pharmacol Pharm; 1981 Oct; 33(3):299-303. PubMed ID: 7198778
[TBL] [Abstract][Full Text] [Related]
14. Quercetin potentiates L-Dopa reversal of drug-induced catalepsy in rats: possible COMT/MAO inhibition.
Singh A; Naidu PS; Kulkarni SK
Pharmacology; 2003 Jun; 68(2):81-8. PubMed ID: 12711835
[TBL] [Abstract][Full Text] [Related]
15. Effect of drugs influencing central 5-hydroxytryptaminergic mechanisms on molindone-induced catalepsy in the rat.
Balsara JJ; Nandal NV; Gada VP; Chandorkar AG
J Pharm Pharmacol; 1981 Jun; 33(6):392-4. PubMed ID: 6115017
[No Abstract] [Full Text] [Related]
16. Differential dose- and time-dependent effects of molindone on dopamine neurons of rat brain: mediation by irreversible inhibition of monoamine oxidase.
Meller E; Friedman E
J Pharmacol Exp Ther; 1982 Mar; 220(3):609-15. PubMed ID: 6121048
[TBL] [Abstract][Full Text] [Related]
17. Acute increases by p-chlorophenylalanine of apomorphine-induced stereotyped behavior in the rat.
Baldessarini RJ; Griffith FF
Psychopharmacology (Berl); 1976 Jul; 48(1):91-5. PubMed ID: 135269
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic-induced catalepsy: a D2 blockade phenomenon?
Klemm WR
Pharmacol Biochem Behav; 1985 Dec; 23(6):911-5. PubMed ID: 2867564
[TBL] [Abstract][Full Text] [Related]
19. Influences of diterpene sclareol glycol on some dopamine related behavior.
Georgieva JV
Gen Pharmacol; 1991; 22(2):331-5. PubMed ID: 2055429
[TBL] [Abstract][Full Text] [Related]
20. Effects of yohimbine on dopamine dependent behaviours in rats and mice.
Bende MM; Bapat TR; Balsara JJ; Chandorkar AG
Indian J Physiol Pharmacol; 1990 Jul; 34(3):195-200. PubMed ID: 2286423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
